CCCTC-Binding Factor
/ genetics
Carcinoma, Ovarian Epithelial
/ genetics
Cell Line, Tumor
Cell Proliferation
/ physiology
Cystadenocarcinoma, Serous
/ genetics
DNA-Binding Proteins
/ biosynthesis
Fallopian Tubes
/ metabolism
Female
Humans
N-Acetylgalactosaminyltransferases
/ genetics
Neoplasm Invasiveness
Ovarian Neoplasms
/ genetics
Promoter Regions, Genetic
Transfection
Journal
Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
21
03
2019
revised:
07
06
2019
accepted:
03
07
2019
pubmed:
12
7
2019
medline:
17
7
2020
entrez:
12
7
2019
Statut:
ppublish
Résumé
High-grade serous carcinoma (HGSC) is the most aggressive and predominant form of epithelial ovarian cancer and the leading cause of gynecologic cancer-related death. We have previously shown that
Identifiants
pubmed: 31292201
pii: 1541-7786.MCR-19-0310
doi: 10.1158/1541-7786.MCR-19-0310
pmc: PMC6943826
mid: NIHMS1534114
doi:
Substances chimiques
CCCTC-Binding Factor
0
CTCF protein, human
0
CTCFL protein, human
0
DNA-Binding Proteins
0
N-Acetylgalactosaminyltransferases
EC 2.4.1.-
UDP-N-acetyl-D-galactosamine polypeptide N-acetylgalactosaminyltransferase 14, human
EC 2.4.1.41
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2051-2062Subventions
Organisme : NCI NIH HHS
ID : P50 CA159981
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA197996
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA036727
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009476
Pays : United States
Organisme : NCI NIH HHS
ID : F99 CA212470
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016056
Pays : United States
Informations de copyright
©2019 American Association for Cancer Research.
Références
Cell. 2008 Feb 8;132(3):422-33
pubmed: 18237772
Cancer Res. 2005 Sep 1;65(17):7763-74
pubmed: 16140944
Oncotarget. 2015 Dec 22;6(41):43843-52
pubmed: 26549805
Clin Cancer Res. 2011 Apr 15;17(8):2170-80
pubmed: 21296871
Curr Opin Genet Dev. 2014 Feb;24:8-15
pubmed: 24657531
PLoS One. 2012;7(4):e34915
pubmed: 22532833
PLoS Genet. 2016 Mar 28;12(3):e1005940
pubmed: 27019336
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6806-11
pubmed: 12011441
Cancer Lett. 2017 Sep 10;403:165-174
pubmed: 28645561
Sci Rep. 2017 Feb 01;7:41279
pubmed: 28145452
Oncotarget. 2014 Feb 28;5(4):1052-61
pubmed: 24658009
Development. 2018 Mar 22;145(6):
pubmed: 29567640
Cancer Immunol Immunother. 2018 Dec;67(12):1955-1965
pubmed: 30390146
Cancer Res. 2014 Feb 15;74(4):1141-52
pubmed: 24366882
Int J Cancer. 2008 Feb 15;122(4):777-84
pubmed: 17957795
Mol Cell Biol. 2010 May;30(10):2473-84
pubmed: 20231363
Clin Cancer Res. 2008 Jun 1;14(11):3283-90
pubmed: 18519754
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Nucleic Acids Res. 2018 Aug 21;46(14):7097-7107
pubmed: 29860503
PLoS One. 2014 Oct 03;9(10):e109921
pubmed: 25279549
Oncol Rep. 2013 Aug;30(2):667-76
pubmed: 23708057
Nature. 2015 May 28;521(7553):489-94
pubmed: 26017449
Annu Rev Pathol. 2014;9:27-45
pubmed: 23937438
Mol Carcinog. 2015 Oct;54(10):1159-71
pubmed: 24962947
Nat Commun. 2016 Jan 27;7:10499
pubmed: 26813108
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
PLoS One. 2015 Jul 17;10(7):e0132977
pubmed: 26185996
J Clin Oncol. 2007 Jul 10;25(20):2921-7
pubmed: 17617523
Eur J Cancer. 2012 Apr;48(6):929-35
pubmed: 22019212
Nat Protoc. 2012 Sep;7(9):1755-64
pubmed: 22936217
Cancer Res. 2005 Sep 1;65(17):7751-62
pubmed: 16140943
Cancer Sci. 2012 Sep;103(9):1617-24
pubmed: 22676270
Oncotarget. 2015 Sep 29;6(29):27613-27
pubmed: 26243836
Genome Biol. 2015 Aug 14;16:161
pubmed: 26268681
J Biol Chem. 2018 Jun 1;293(22):8449-8461
pubmed: 29610276
Cancer Immun. 2010 Jul 23;10:6
pubmed: 20649179
Mol Cancer Res. 2016 Sep;14(9):787-94
pubmed: 27259716
Sci Rep. 2018 Nov 20;8(1):17136
pubmed: 30459449
EMBO J. 2008 Nov 5;27(21):2839-50
pubmed: 18923423
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10231-3
pubmed: 12149519
J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12
pubmed: 2359136
Cancer Res. 2008 Jul 15;68(14):5546-51
pubmed: 18632606
Cancer Immun. 2007 Dec 21;7:21
pubmed: 18095639
Nucleus. 2018 Jan 1;9(1):33-41
pubmed: 29077515
PLoS One. 2012;7(7):e40389
pubmed: 22792300
Epigenetics Chromatin. 2012 Jun 18;5(1):8
pubmed: 22709888
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):633-8
pubmed: 12524457
Mol Cancer. 2014 Dec 11;13:263
pubmed: 25496021
J Pathol. 2007 Jan;211(1):26-35
pubmed: 17117391
Genome Res. 2014 Aug;24(8):1285-95
pubmed: 24812327